Product Launch (Blog)

Jun, 17 2024

Leading Innovators in the Global Neurosurgery Market: A Spotlight on Medtech Giants

Neurosurgery, a specialized medical field, encompasses the diagnosis and surgical treatment of neurological disorders affecting the brain, spinal cord, and peripheral nerves. A notable application within the global neurosurgery market is the utilization of minimally invasive techniques. These methods, including endoscopic procedures and stereotactic radiosurgery, offer patients reduced pain, shorter hospital stays, and faster recovery times compared to traditional open surgeries. Furthermore, minimally invasive approaches minimize the risk of complications and enhance overall patient outcomes. This shift towards less invasive interventions is a significant driver of growth within the neurosurgery market on a global scale.

The Global Neurosurgery Market valued at is projected to reach USD 20,679.72 million by 2029, and will grow at a CAGR of 14.20% during the forecast period of 2022-2029.

Below are the Top Neurosurgery companies with a Significant Market Share:




Product Portfolio

Sales Geographical Coverage




As a global leader in medical technology, Medtronic offers a wide range of neurosurgery solutions, including devices for brain and spinal surgery, deep brain stimulation systems, and neurovascular intervention products. With a focus on innovation and patient-centric care, Medtronic plays a pivotal role in advancing neurosurgical techniques and improving outcomes for patients worldwide.


Europe, Middle East and Africa, Americas, and Asia-Pacific

In March 2022, Medtronic, a global leader in healthcare technology, announced their first patient implants in the TITAN 2 pivotal study that evaluated the safety and efficacy of Medtronic's investigational implantable tibial neuromodulation (TNM) device in people with overactive bladder (OAB). Implantable TNM has the potential to give relief to millions who suffer from bladder incontinence through a new approach that provides greater convenience and more options for physicians and patients. This will help the company to evaluate the safety and efficacy of its products.



Stryker is a prominent player in the neurosurgery market, offering a comprehensive portfolio of products ranging from neurosurgical instruments and implants to imaging technologies. The company's commitment to research and development drives the creation of innovative solutions for complex neurosurgical procedures, enhancing precision and efficacy in treatment.

  • Stryker NAV3i
  • Stryker ADAPT
  • Maestro Drill
  • S2 Mini Drill System
  • Sumex Drill

Europe, Middle East and Africa, South America, South America, and Asia-Pacific

In May 2019, Stryker announced today the premarket approval (PMA) of the Neuroform Atlas Stent System by the U.S. FDA.  Neuroform Atlas is only the second aneurysm adjunctive stent to be permitted PMA approval for the treatment of wide-neck, intracranial aneurysms in conjunction with embolic detachable coils. The neuroform atlas stent is indicated for use with neurovascular embolization coils in the anterior circulation of the neurovasculature for the endovascular treatment of patients. This product is changing clinical practice and is an option for endovascular treatment while improving the quality and safety of treatment. This approval has helped the company increase its global presence and sales and revenue.



Abbott is known for its contributions to the neurosurgery market through its neuromodulation division, which develops implantable devices for chronic pain management, movement disorders, and epilepsy. With a focus on delivering personalized therapies and improving patient outcomes, Abbott continues to make strides in advancing neurostimulation technologies.

  • Proclaim Elite Recharge-Free SCS System
  • Proclaim XR SCS system
  • St. Jude Medical Invisible Trial System
  • Prodigy MRI SCS System

Europe, Middle East and Africa, Americas, and Asia-Pacific

In April 2022, Abbott announced that it had launched an upgraded version of its NeuroSphere myPath digital health app with enhanced functionality that will help doctors more closely track their patients as they trial Abbott neurostimulation devices to address their chronic pain. This upgrade is part of Abbott's commitment to connected care technology and is intended to put people in control of their health and facilitate better communication with their doctors. This has helped the company to enhance its product use by launching the app.


Boston Scientific Corporation or its affiliates

Boston Scientific is a key player in the neurosurgery market, offering a diverse array of products for neurovascular intervention, deep brain stimulation, and chronic pain management. The company's commitment to research and collaboration drives innovation in neurosurgical treatments, addressing unmet clinical needs and improving patient quality of life.

  • Vercise DBS System
  • Vercise Genus Deep Brain Stimulation System
  • Vercise Gevia DBS System
  • Precision Spectra
  • Precision Plus

Europe, Middle East and Africa, Americas, and Asia-Pacific

In April 2022, Boston Scientific Corporation or its affiliates announced it had received U.S. Food and Drug Administration (FDA) approval for its latest image-guided programming software, Vercise Neural Navigator, with STIMVIEW XT. Developed in collaboration with Brainlab AG, a leading software-driven medical technology company. This has helped the company to expand its product portfolio.


Integra Lifesciences

Integra Lifesciences specializes in neurosurgery solutions, providing a comprehensive portfolio of implants, instruments, and systems for cranial and spinal procedures. With a focus on innovation and clinical excellence, Integra Lifesciences continues to drive advancements in neurosurgical technology, enabling surgeons to deliver superior patient care and outcomes.

  • Cushing Perforator Drill
  • D'Errico Perforator Drill
  • Hudson Drill Set
  • DuraGen Classic
  • McKenzie Perforator Drill

Europe, Middle East and Africa, North America, Latin America, and Asia-Pacific

In February 2022, Integra LifeSciences was recognized as a Great Place to Work in China. They deliver lifesaving neurosurgical medical technologies to customers and patient communities. This honor will help strengthen the corporate brand, enhance credibility among the customers, assist in recruitment efforts, and help the company build a global presence.


In the market, companies such as Medtronic, Stryker, Abbott, Boston Scientific Corporation, and Integra Lifesciences play integral roles in advancing neurosurgical care. Through their innovative products and technologies, these companies contribute to improved patient outcomes, enhanced surgical precision, and expanded treatment options for neurological disorders worldwide. Their ongoing commitment to research, development, and collaboration underscores their dedication to addressing evolving clinical needs and driving continued progress in neurosurgery. As key leaders in the field, they are poised to shape the future of neurosurgical interventions and ultimately improve the lives of patients facing complex neurological conditions.

Client Testimonials